Cancer cells acquire resistance due to a number of factors including changes in DNA repair mechanisms, limitations in the uptake of chemotherapeutics agents, as well as the active efflux of agents out of the cell, such as via ATP-binding cassette (ABC) transporters [21]. The gene discussed is ABCG2; the disease is cancer.